Evaluation of Lung Fibrosis on HRCT: Right Upper Lobe, Posterior Right Lung, and Upper Left Lower Lobe
The evaluation must begin with a systematic multidisciplinary approach integrating clinical assessment, detailed exposure history, pulmonary function tests, and consideration of surgical lung biopsy or transbronchial cryobiopsy when HRCT patterns are not definitive for usual interstitial pneumonia (UIP). 1
Initial Clinical Assessment
Critical History Elements to Obtain
Exposure Assessment - This is paramount given your HRCT distribution pattern:
- Environmental antigens: Bird exposure, mold, hot tubs, humidifiers, feather bedding 2, 3
- Occupational exposures: Organic dusts, chemicals, mineral particles (silica, asbestos) 1
- Medication history: Drug-induced ILD must be excluded 1
- Smoking history: Current/former smoking status and pack-years 4, 5
Connective Tissue Disease Screening - Essential to exclude CTD-ILD:
- Systemic sclerosis, rheumatoid arthritis, Sjögren's syndrome, mixed connective tissue disease, inflammatory myopathies, systemic lupus erythematosus 1, 6
- Look for: Raynaud's phenomenon, arthralgias, dry eyes/mouth, skin changes, muscle weakness
- Obtain autoimmune serology panel 6
Physical Examination Findings:
- Bibasilar inspiratory "velcro" crackles (suggests fibrosis) 1, 6
- Digital clubbing (present in <50% of IPF cases) 1
- Signs of connective tissue disease 6
HRCT Pattern Analysis
Your specific distribution (R upper lobe, posterior R lung, upper L lower lobe) is atypical for IPF, which characteristically shows subpleural, basal predominance 1, 4. This distribution raises several diagnostic considerations:
Key HRCT Features to Document:
Fibrotic patterns to identify:
- Honeycombing: Clustered cystic airspaces with thick walls, subpleural location 1
- Traction bronchiectasis/bronchiolectasis: Indicates established fibrosis 1, 3
- Reticulation: Irregular linear opacities 1
Features suggesting alternative diagnoses:
- Centrilobular nodules: Strongly suggests hypersensitivity pneumonitis over IPF 3, 1, 7
- Mosaic attenuation: Suggests small airways disease, common in HP 3, 1
- Ground-glass opacity:
- Upper/mid-lung predominance: Atypical for IPF; consider HP, sarcoidosis, silicosis 8, 3
Diagnostic Algorithm Based on HRCT Pattern
If HRCT Shows Definite UIP Pattern:
- Subpleural, basal honeycombing with reticulation and traction bronchiectasis
- No other features suggesting alternative diagnosis
- Diagnosis of IPF can be made without biopsy IF other ILD causes excluded 1
If HRCT Shows Possible UIP or Indeterminate Pattern (Your Case):
Given your atypical distribution, this likely applies:
Proceed to tissue diagnosis via:
Consider bronchoalveolar lavage (BAL):
Pulmonary Function Testing
Mandatory baseline tests 1:
- Forced vital capacity (FVC) and total lung capacity: Restrictive pattern expected
- DLCO: Early and sensitive marker of ILD; typically reduced
- 6-minute walk test: Assess exercise capacity and oxygen desaturation
- Resting arterial blood gas
Multidisciplinary Discussion
All cases require MDD involving 1, 4:
- Pulmonologist experienced in ILD
- Thoracic radiologist
- Pathologist (if biopsy obtained)
Complex cases should be referred to expert ILD centers 1
Differential Diagnosis for Your Distribution Pattern
Given the upper lobe and posterior involvement, prioritize:
Hypersensitivity pneumonitis (fibrotic):
Connective tissue disease-ILD:
Chronic silicosis or asbestosis:
- Upper lobe predominance in silicosis
- Look for pleural plaques in asbestosis 8
Sarcoidosis:
Atypical IPF/UIP:
- Less common but possible 10
Critical Pitfalls to Avoid
- Do not diagnose IPF without excluding CTD and exposures - autoimmune serologies and detailed exposure history are mandatory 1
- Do not rely on HRCT alone when pattern is atypical - your distribution warrants tissue diagnosis 1
- Do not miss centrilobular nodules - these strongly favor HP over IPF 3, 7
- Do not perform biopsy without risk assessment - age, comorbidities, and disease severity affect operative risk 1